Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Autolus Therapeutics (AUTL) Income from Continuing Operations (2017 - 2025)

Historic Income from Continuing Operations for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$79.1 million.

  • Autolus Therapeutics' Income from Continuing Operations rose 362.51% to -$79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.8 million, marking a year-over-year increase of 1680.99%. This contributed to the annual value of -$220.7 million for FY2024, which is 589.25% down from last year.
  • Per Autolus Therapeutics' latest filing, its Income from Continuing Operations stood at -$79.1 million for Q3 2025, which was up 362.51% from -$47.9 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Income from Continuing Operations registered a high of -$6.8 million during Q4 2021, and its lowest value of -$44.8 billion during Q3 2021.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$45.8 million (2023), whereas its average is -$2.4 billion.
  • As far as peak fluctuations go, Autolus Therapeutics' Income from Continuing Operations tumbled by 8428307.1% in 2021, and later soared by 9990.45% in 2022.
  • Autolus Therapeutics' Income from Continuing Operations (Quarter) stood at -$6.8 million in 2021, then tumbled by 298.16% to -$27.0 million in 2022, then crashed by 186.04% to -$77.2 million in 2023, then soared by 64.23% to -$27.6 million in 2024, then crashed by 186.6% to -$79.1 million in 2025.
  • Its Income from Continuing Operations was -$79.1 million in Q3 2025, compared to -$47.9 million in Q2 2025 and -$70.2 million in Q1 2025.